Topical prostaglandin analogues and development of epiretinal membrane

Joshi M, Agrawal S, Christoforidis JB. Inflammatory mechanisms of idiopathic epiretinal membrane formation. Mediators Inflamm. 2013; 2013:192582. DOI: https://doi.org/10.1155/2013/192582

Knyazer B, Schachter O, Plakht Y, et al. Epiretinal membrane in diabetes mellitus patients screened by nonmydriatic fondo camera. Can J Ophthalmol. 2016; 51:41-6. DOI: https://doi.org/10.1016/j.jcjo.2015.09.016

Miranda AF, Costa de Andrade G, et al. Outcomes after pars plana vitrectomy for epirretinal membranes associated with toxoplasmosis. Retina. 2016; 36:1713-7. DOI: https://doi.org/10.1097/IAE.0000000000000973

Fraser-Bell S, Guzowski M, Rochtchina E, et al. Five-year cumulative incidence and progression of epirretinal membranes: The Blue Mountains Eye Study. Ophthalmology. 2003; 110:34-40. DOI: https://doi.org/10.1016/S0161-6420(02)01443-4

Sebag J. Anomalous posterior vitreous detachment: A unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol. 2004; 242:690-8. DOI: https://doi.org/10.1007/s00417-004-0980-1

Schumer RA, Camras CB, Mandahl AK. Putative side effects of prostaglandin analogs. Surv Ophthalmol. 2002; 47(Suppl 1):S219. DOI: https://doi.org/10.1016/S0039-6257(02)00328-4

Varma R, Ying-Lai M, Francis BA, et al. Los Angeles Latino Eye Study Group. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: The Los Angeles Latino Eye Study. Ophthalmology. 2004; 111:1439-48. DOI: https://doi.org/10.1016/j.ophtha.2004.01.025

Chu CJ, Johnston RL, Buscombe C, et al. United Kingdom Pseudophakic Macular Edema Study Group. Risk factors and incidence of macular edema after cataract surgery: A database study of 81984 eyes. Ophthalmology. 2016; 132:316-23. DOI: https://doi.org/10.1016/j.ophtha.2015.10.001